News
Warning! Ibuprofen Linked to Male Infertility, Ulcer

Ibuprofen has a negative impact on the testicles of young men, a study published Monday in the journal Proceedings of the National Academy of Sciences found.
Also, Pharmaceutical Society of Nigeria (PSN) on Tuesday warned against self-medication and particularly misuse of Ibuprofen which could expose one to stomach ulcer.
When taking ibuprofen in doses commonly used by athletes, a small sample of young men developed a hormonal condition that typically begins, if at all, during middle age. This condition is linked to reduced fertility.
Advil and Motrin are two brand names for ibuprofen, an over-the-counter pain reliever. CNN has contacted Pfizer and Johnson & Johnson, the makers of both brands, for comment.
The Consumer Healthcare Products Association, a trade group that represents manufacturers of over-the-counter medications and supplements, “supports and encourages continued research and promotes ongoing consumer education to help ensure safe use of OTC medicines,” said Mike Tringale, a spokesman for the association.
“The safety and efficacy of active ingredients in these products has been well documented and supported by decades of scientific study and real-world use.”
The new study is a continuation of research that began with pregnant women, explained Bernard Jégou, co-author and director of the Institute of Research in Environmental and Occupational Health in France.
Jégou and a team of French and Danish researchers had been exploring the health effects when a mother-to-be took any one of three mild pain relievers found in medicine chests around the globe: aspirin, acetaminophen (also known as paracetamol and sold under the brand name Tylenol) and ibuprofen.
Their early experiments, published in several papers, showed that when taken during pregnancy, all three of these mild medicines affected the testicles of male babies.
Testicles and testosterone
Testicles not only produce sperm, they secrete testosterone, the primary male sex hormone. All three drugs then are “anti-androgenic,” meaning they disrupt male hormones, explained David M. Kristensen, study co-author and a senior scientist in the Department of Neurology at Copenhagen University Hospital.
The three drugs even increased the likelihood that male babies would be born with congenital malformations, Kristensen noted. Tringale noted that pregnant and nursing women should always ask a health professional before using medicines.
Knowing this, “we wondered what would happen in the adult,” he said. They focused their investigation on ibuprofen, which had the strongest effects.
A non-steroidal anti-inflammatory drug, ibuprofen is often taken by athletes, including Olympians and professional soccer players for example, before an event to prevent pain, Jégou said. Are there health consequences for the athletes who routinely use this NSAID?
The research team recruited 31 male volunteers between the ages of 18 and 35. Of these, 14 were given a daily dosage of ibuprofen that many professional and amateur athletes take: 600 milligrams twice a day, explained Jégou. (This 1200-mg-per-day dose is the maximum limit as directed by the labels of generic ibuprofen products.) The remaining 17 volunteers were given a placebo.
For the men taking ibuprofen, within 14 days, their luteinizing hormones — which are secreted by the pituitary gland and stimulate the testicles to produce testosterone — became coordinated with the level of ibuprofen circulating in their blood. At the same time, the ratio of testosterone to luteinizing hormones decreased, a sign of dysfunctional testicles.
This hormonal imbalance produced compensated hypogonadism, a condition associated with impaired fertility, depression and increased risk for cardiovascular events, including heart failure and stroke.
For the small group of young study participants who used ibuprofen for only a short time, “it is sure that these effects are reversible,” Jégou said.
However, it’s unknown whether the health effects of long-term ibuprofen use are reversible, he said. After this randomized, controlled clinical trial, the research team experimented with “little bits of human testes” provided by organ donors and then conducted test tube experiments on the endocrine cells, called Leydig and Sertoli cells, which produce testosterone, explained Jégou.
The point was to articulate “in vivo, ex vivo and in vitro” — in the living body, outside the living body and in the test tube — that ibuprofen has a direct effect on the testicles and so testosterone.
“We wanted to understand what happened after exposure (to ibuprofen) going from the global human physiology over to the specific organ (the testis) down to the endocrine cells producing testosterone,” Kristensen said.
More than idle curiosity prompted such an extensive investigation.
Questions around male fertility
The World Health Organization estimates that one in every four couples of reproductive age in developing countries experiences childlessness despite five years of attempting pregnancy.
A separate study estimated that more than 45 million couples, or about 15% of all couples worldwide, were infertile in 2010, while another unrelated study suggested that men were solely responsible for up to 30% and contribute up to 50% of cases overall.
Meanwhile, a recent analysis published in the journal?Human Reproduction Update found that sperm counts of men in North America, Europe, Australia and New Zealand are plunging. Researchers recorded a 52% decline in sperm concentration and a 59% decline in total sperm count over a nearly 40-year period ending in 2011.
Erma Z. Drobnis, an associate professional practice professor of reproductive medicine and fertility at the University of Missouri, Columbia, noted that most drugs are not evaluated for their effects on human male fertility before marketing. Drobnis, who was not involved in the new study, has done extensive research into sperm biology and fertility.
“There is evidence that some medications are particularly harmful to the male reproductive system, including testosterone, opioids, antidepressants, antipsychotics, immune modulators and even the over-the-counter antacid cimetidine (Tagamet),” she said. “However, prescribing providers rarely mention these adverse effects with patients when prescribing these medications.
She believes the new study, though small, is “important” because ibuprofen is among the most commonly used medications.
Though the new research indicates that ibuprofen disrupts the reproductive hormones in healthy young men, she thinks it’s possible there’s an even greater negative effect in men with low fertility. The other OTC drugs concerning for potential fathers are cimetidine and acetaminophen. She recommends that men who are planning to father a child avoid drugs for several months.
“Larger clinical trials are warranted,” she said. “This is timely work that should raise awareness of medication effects on men and potentially their offspring.”
Jégou agrees that more study is needed to answer many questions, including whether ibuprofen’s effects on male hormones are seen at low doses and whether long-term effects are reversible.
“But the alarm has been raised now,” he said. “if this serves to remind people that we are really dealing with medical drugs — not with things which are not dangerous — this would be a good thing.”
“We need to remember that it is a pharmaceutical compound that helps a lot of people worldwide,” Kristensen said. He noted, though, that of the three mild analgesics examined, ibuprofen had “the broadest endocrine-disturbing properties identified so far in men.”
In Nigeria, PSN, has also warned against self-medication and particularly misuse of Ibuprofen which could expose one to stomach ulcer.
Jelili Kilani, PSN Chairman, FCT Chapter, gave the indication in an interview with the News Agency of Nigeria in Abuja.
He condemned the rate at which people abused the medicine, saying that such uncontrolled usage could bring about body pains and other negative reactions.
The association chief said the consistent use of Ibuprofen could damage the internal body system.
“Ibuprofen is used for the treatment of mild to moderate pain, inflammation and fever caused by many and diverse diseases, and also for treating menstrual cramps.”
The chairman said that in spite of the positive effect of the drug, with regard to fast relieve of pains, if not used according to prescription it could do more harm than good to our health.
“Ibuprofen should not be taking indiscriminately because it affects the gastro intestinal system and the stomach lining, leading to stomach ulcer.
“Most times, body pains is a manifestation of illness within, and consistent taking of the medicine without medical diagnosis, you are compounding your health challenge.
“Such practice will increase cost of treatment of infirmity, and could be suicidal when detected later.
“We should desist from self-medication and seek medical advice for proper and timely intervention.
“Medicine should be used based on doctor’s prescription, to avoid collateral damage to your body system,” Mr. Kilani said.
He, however, urged the general public to desist from self-medication and consult medical doctors, when faced with any health challenge, for proper diagnosis and medication.
News
Kalu Champions African Digital Trade Multilateralism

Benjamin Kalu, deputy Speaker of the House of Representatives, has emphasized the critical role of parliaments in promoting multilateralism through digital trade.
Kalu, according to a statement by his Chief Press Secretary (CPS), Levinus Nwabughiogu, stated this at the World Trade Organization/Inter-Parliamentary Union (WTO-IPU) Steering Committee session of the WTO Public Forum 2025 on the sidelines of the ongoing 55th Parliamentary Conference, Geneva, Switzerland.
The statement noted that the deputy speaker, who spoke on the theme “Promoting Multilateralism Through Digital Trade: What Role for Parliaments?”, stated that digital trade is a defining contemporary governance challenge that shapes the daily reality of entrepreneurs and the future opportunities for youth.
He stated that that Africa is proactively building its own regional multilateralism through the African Continental Free Trade Area (AfCFTA) and its Protocol on Digital Trade, aiming for a harmonized and integrated digital market.
Kalu, while citing Nigeria’s legislative actions, including the Nigeria Data Protection Act of 2023 and the forthcoming National Digital Economy Bill, stressed that parliaments across Africa are also actively legislating the future of digital trade.
According to him, “the digital economy is no longer a distant promise; it is the daily reality of our entrepreneurs and the horizon of opportunity for our youth. In Africa, we have chosen not to wait for others to write our future.
“Through the African Continental Free Trade Area (AfCFTA) and its Protocol on Digital Trade, we are building our own regional multilateralism, a blueprint for a harmonized, integrated digital market.
“But blueprints alone do not build houses. Success depends on the laws we pass, the trust we create, and the predictability we guarantee. In Nigeria, we have acted: the Nigeria Data Protection Act of 2023 safeguards privacy, while the forthcoming National Digital Economy Bill will anchor e-commerce and investment in legal certainty.
“Across Africa, parliaments are not spectators; we are legislating the future. Let us be frank, rules without enforcement are illusions. For smaller economies, a binding, two-tier dispute settlement system is not optional; it is survival.”
He added that “we all know that speeches do not build futures; actions do. For us to move to coordinated action, I propose three steps: a Legislative Tracking Mechanism that engenders peer‑to‑peer accountability, requiring us to report back on how we translate our collective resolutions into concrete action within our national parliaments; Concrete WTO support for AfCFTA implementation to further deepen digital trade in Africa; and a Model Digital Trade Legislative Toolkit developed with UNCTAD and ITC, to equip parliaments with best-practice laws for a pro-development digital economy.”
News
Nigeria Launches 24-Hour Passport Processing, Boosting Capacity to 5,000 Daily

Nigeria has upgraded its passport production system to meet global standards, now able to process up to 5,000 passports every day.
According to TVC, Dr. Olubunmi Tunji-Ojo, minister of Interior, disclosed this during an inspection of the new Centralised Passport Personalisation Centre at the Nigeria Immigration Service headquarters in Abuja.
He explained that the development is part of President Bola Ahmed Tinubu’s Renewed Hope Agenda, which has cleared backlogs and ended long delays in passport processing.
According to him, Nigerians can now get their approved passports within 24 hours.
“The era of backlogs and manual personalisation is over. Nigerians can now expect faster, more reliable service as we strengthen the integrity of our travel documents,” Tunji-Ojo said.
The Minister added that Nigeria has now joined countries like the United States, the United Kingdom, France, and India in adopting advanced passport systems that ensure speed, transparency, and global authentication.
He also commended the Permanent Secretary, Dr. Magdalene Ajani, Comptroller-General of Immigration, Mrs. Kemi Nandap, and other key officials for their contributions.
Tunji-Ojo stressed that the project, delivered through a partnership with IRIS Smart Technologies Ltd., was achieved without direct government funding.
“This project underscores our resolve to build enduring institutions rather than systems dependent on individuals,” he said.
With the new system, production has moved from 250–300 booklets per machine daily to between 4,500 and 5,000.
The Minister described the achievement as a major milestone in Nigeria’s 62-year Immigration Service history, saying it has restored confidence in the country’s travel documents.
News
AfDB Approves Equity Investment in The Currency Exchange Fund to Support Access to Local Currency Financing Across Africa

The Board of Directors of the African Development Bank Group has approved an equity investment of USD 25 million in The Currency Exchange Fund (TCX), a global leader in offering long-term local currency hedging solutions in emerging and frontier markets.
This strategic investment will strengthen TCX’s capital base, enhance its risk-bearing capacity, and expand its ability to offer hedging instruments in illiquid and less liquid currencies across the African continent.
The transaction will help mitigate the foreign exchange risks faced by borrowers in Africa, particularly those operating in fragile states and underserved markets. TCX operates as a development-focused fund that provides tailor-made FX hedging instruments to enable local currency lending in countries where conventional hedging markets are either underdeveloped or non-existent.
The Bank’s investment will crowd in additional DFIs and private investors, reinforce Africa’s integration into global capital markets, and support sustainable growth by reducing the mismatch between the currency of debt and revenue for local borrowers.
Ahmed Attout, Director of the financial Sector Development Department, at the African Development Bank Group, stated: “This investment in TCX marks an important milestone in the Bank’s effort to deepen African capital markets and address the root causes of debt distress. The Bank’s support to TCX will unlock local currency financing for MSMEs, infrastructure and many sectors across Africa.”
He added : “The transaction forms part of the Bank’s broader objective to promote access to adequate financing through innovative alternative solutions.”
The investment builds on the Bank’s prior participation in TCX and reflects its continued confidence in the fund’s track record and impact-driven model. TCX has hedged more than USD 17 billion in notional amounts since inception, including over USD 4 billion across 31 African countries.
The Bank’s participation is expected to facilitate increased hedging volumes in priority sectors such as the public sector (Debt Management Offices and Public Development Banks), infrastructure, energy access, microfinance, and SME development. TCX also plays a unique role in fragile and low-income countries, with around 18% of its global outstanding portfolio currently focused on such markets.
Ruurd Brouwer, TCX’s Chief Executive Officer stated : “We are thrilled to welcome African Development Bank Group to TCX’s capital base, joining fellow development finance institutions, impact investors and governments that support our local currency hedging solution. It marks the start of a close partnership in protecting AfDB’s public and private sector borrowers from currency risk and promoting the development of African capital markets. We very much look forward to increasing our joint impact on the continent.”
This operation is aligned with the Bank’s Ten-Year Strategy 2024–2033. It complements the Bank’s broader capital markets strategy, which includes support for local currency bond issuance, Partial Credit Guarantees, and private sector local currency lending.
The investment is expected to deliver strong development impact. The African Development Bank remains committed to fostering resilient capital markets in Africa, supporting de-risking mechanisms for the private sector, and expanding access to local currency finance to promote inclusive and sustainable development.
- E-Financial2 days ago
FCMB Partners Truecaller to Reinforce Customer Communication, Trust
- News2 days ago
AfDB Approves Equity Investment in The Currency Exchange Fund to Support Access to Local Currency Financing Across Africa
- E-Financial2 days ago
Don’t Spray, Mutilate Naira – CBN
- General News2 days ago
Why Elon Musk Halted Sales of Starlink in Lagos, Abuja
- Broadcasting2 days ago
Glo-sponsored African Voices Features Star Author, Chimamanda Adichie
- News2 days ago
Shoprite Struggles to Stay Afloat as Stores Shut across Nigeria
- Telecom2 days ago
Google Expands Digital Infrastructure with Four New Subsea Cable Hubs and $9m AI Fund for Africa
- E-Business2 days ago
FG Plans to Make 95 Percent of Nigerians Digitally Literate by 2030